Option Care Health, Inc.
OPCH
Pozycja w akcjach
#3630
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Cena akcji
$31.22
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$4.68B
Zmiana (1 dzień)
0.06%
Zmiana (1 rok)
10.01%
Kraj
US
Handel Option Care Health, Inc. (OPCH)
Kategoria
Healthcare
Zyski dla Option Care Health, Inc. (OPCH)
Zyski w Jun 2026 TTM: $285.47M
Według najnowszych raportów finansowych Option Care Health, Inc., obecny zysk firmy wynosi $285.47M. W roku 2023 firma osiągnęła zysk w wysokości $358.74M, wzrost w porównaniu do zysku z roku 2022, który wynosił $205.77M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Option Care Health, Inc. od 2000 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $285.47M | 0.66% |
| 2024 | $283.60M | -20.95% |
| 2023 | $358.74M | 74.34% |
| 2022 | $205.77M | 76.63% |
| 2021 | $116.49M | -2,321.90% |
| 2020 | $-5.24M | -93.29% |
| 2019 | $-78.19M | 791.81% |
| 2018 | $-8.77M | -87.00% |
| 2017 | $-67.43M | 97.42% |
| 2016 | $-34.16M | -89.53% |
| 2015 | $-326.35M | 135.25% |
| 2014 | $-138.73M | 97.11% |
| 2013 | $-70.38M | 262.94% |
| 2012 | $-19.39M | -176,390.91% |
| 2011 | $11.00K | -100.06% |
| 2010 | $-18.98M | -240.08% |
| 2009 | $13.55M | -115.71% |
| 2008 | $-86.23M | -1,645.03% |
| 2007 | $5.58M | -128.98% |
| 2006 | $-19.26M | -34.92% |
| 2005 | $-29.60M | -357.66% |
| 2004 | $11.49M | -24.52% |
| 2003 | $15.22M | -34.85% |
| 2002 | $23.36M | 54.33% |
| 2001 | $15.13M | -983.48% |
| 2000 | $-1.71M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $9.87B | 3,357.77% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 1,253.89% |
US
|
|
| $687.82M | 140.94% |
SA
|
|
| $1.25B | 336.72% |
BR
|
